Growth rate-corrected (GR) dose-response metrics across a panel of 71 breast cancer cell lines treated with a library of small molecule and antibody perturbagens. Dataset 2 of 4: Calculated dose-response metrics. - Dataset (ID:20269)

Filter results: >>>>
Cell Clinical Subtype Transcriptional Subtype Small Molecule Antibody Perturbagen Target Perturbagen Class Biological Replicate ID Conc Unit GR50 GEC50 GRmax GRinf GR Hill Coefficient GR_AOC GR r2 Nominal Division Rate
HCC38
TNBC
Basal B
IKK16
IKK
NFKB
7468.093
uM
3.10130
3.93350
-0.9724 -0.9753 4.5519 0.4375
0.9948
1.4007
HCC38
TNBC
Basal B
IKK16
IKK
NFKB
10578.1
uM
3.41280
4.23020
-0.9511 -0.9525 4.9669 0.4114
0.9978
1.6202
HCC38
TNBC
Basal B
IKK16
IKK
NFKB
10418.093
uM
2.8280
3.64580
-0.9969 -0.9995 4.3238 0.4160
0.9980
0.9872
HCC38
TNBC
Basal B
Imatinib
ABL/KIT/PDGFR
nRTK
7468.091
uM
28.77820
39.13170
-0.9542 -0.9566 3.4794 0.4170
0.9973
1.4852
HCC38
TNBC
Basal B
Imatinib
ABL/KIT/PDGFR
nRTK
7469.09
uM
31.10950
37.74430
-0.8139 -0.8145 5.0000 0.3409
0.9987
1.9867
HCC38
TNBC
Basal B
Ispinesib
KSP
Kinesin
7469.067
uM
0.07733
1.16220
-0.8905 -1.0000 0.4054 0.5746
0.8759
2.0639
HCC38
TNBC
Basal B
Ispinesib
KSP
Kinesin
7468.067
uM
0.03607
0.04789
-0.9792 -0.4267 2.1770 0.6782
0.9050
1.3847
HCC38
TNBC
Basal B
Ixabepilone
TUBB
TUBB
7469.095
uM
0.00310
0.00497
-0.9048 -0.5016 1.4776 1.0099
0.9446
1.8946
HCC38
TNBC
Basal B
Ixabepilone
TUBB
TUBB
10418.095
uM
0.00180
0.00302
-0.9979 -0.6317 1.5781 1.1635
0.950
1.1425
HCC38
TNBC
Basal B
Ixabepilone
TUBB
TUBB
7468.095
uM
0.00356
0.00561
-0.9857 -0.5908 1.7194 1.0633
0.9517
1.4474
HCC38
TNBC
Basal B
JNK-IN-5A
JNK
JNK
11850.144
uM
inf
inf
-0.3875 -0.3875 0.0000 0.2825
0.5730
1.9379
HCC38
TNBC
Basal B
JNK-IN-5A
JNK
JNK
10578.144
uM
1.14360
1.43410
-0.2997 -0.2616 1.8588 0.4742
0.9910
1.6376
HCC38
TNBC
Basal B
L-779450
BRAF
MAPK
10578.137
uM
inf
inf
0.6868 0.6868 0.0000 0.0974
0.3820
1.8268
HCC38
TNBC
Basal B
L-779450
BRAF
MAPK
11850.161
uM
16.610
26.65170
-0.6253 -1.0000 2.3234 0.1644
0.9876
2.0754
HCC38
TNBC
Basal B
Lapatinib
EGFR/HER2
ErbB
7469.098
uM
inf
inf
0.9936 0.9936 0.0000 0.0222
0.1591
2.0111
HCC38
TNBC
Basal B
LBH589
HDAC
HDAC
11850.154
uM
0.03768
0.07313
-0.8586 -0.8644 1.5138 0.8966
0.9989
1.9115
HCC38
TNBC
Basal B
Lestaurtinib
FLT3/JAK2/TrkA
RTK
10578.142
uM
0.12314
0.46379
-0.9049 -0.8797 0.7654 0.7903
0.9811
1.8112
HCC38
TNBC
Basal B
Lestaurtinib
FLT3/JAK2/TrkA
RTK
11850.154
uM
0.06337
0.12325
-0.8817 -0.7524 1.3804 0.7578
0.9859
1.9115
HCC38
TNBC
Basal B
Mebendazole
12617.174
uM
0.35225
0.53461
-0.3927 -0.2560 0.9909 0.4554
0.9683
1.5935
HCC38
TNBC
Basal B
Methotrexate
DHFR
Metabolism
7469.084
uM
inf
inf
0.8890 0.8890 0.0000 0.0716
0.0139
2.0377
HCC38
TNBC
Basal B
Methotrexate
DHFR
Metabolism
7468.085
uM
inf
0.11591
0.8106 0.8307 4.9561 0.1077
0.9157
1.4385
HCC38
TNBC
Basal B
Methylglyoxal
13635.184
uM
inf
inf
-0.7403 -0.7403 0.0000 0.4439
0.5429
1.5062
HCC38
TNBC
Basal B
MG-132
Proteasome
Proteasome
14212.189
uM
inf
inf
0.4852 0.4852 0.0000 0.5240
0.4451
1.6254
HCC38
TNBC
Basal B
MG-132
Proteasome
Proteasome
14212.189
uM
inf
inf
0.4852 0.4852 0.0000 0.5240
0.4451
1.6254
HCC38
TNBC
Basal B
MG-132
Proteasome
Proteasome
10578.145
uM
0.2760
0.45953
-0.9775 -0.9583 2.0996 0.7930
0.9951
1.6766